Inhibition of cell proliferation and migration by miR-509-3p that targets CDK2, Rac1, and PIK3C2A

25Citations
Citations of this article
19Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

CDK2 is a key regulator of cell cycle progression. In this study, we screened for miRNAs targeting CDK2 using a luciferase-3′-untranslated region reporter assay. Among 11 hit miRNAs, miR-509-3p reduced CDK2 protein levels and significantly inhibited cancer cell growth. Microarray, Western blotting, and luciferase reporter analyses revealed additional targets of miR-509-3p, including Rac1 and PIK3C2A. Overexpression of miR-509-3p induced G1 cell-cycle arrest and inhibited colony formation and migration. RNAi experiments indicated that the growth-inhibitory effects of miR-509-3p may occur through down-regulation of CDK2, Rac1, and PIK3C2A. Targeting of multiple growth regulatory genes by miR-509-3p may contribute to effective anti-cancer therapy. © The Korean Society for Molecular and Cellular Biology. All rights reserved.

Cite

CITATION STYLE

APA

Yoon, S., Han, E., Choi, Y. C., Kee, H., Jeong, Y., Yoon, J., & Baek, K. (2014). Inhibition of cell proliferation and migration by miR-509-3p that targets CDK2, Rac1, and PIK3C2A. Molecules and Cells, 37(4), 314–321. https://doi.org/10.14348/molcells.2014.2360

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free